unknown
Stage
About
Combotope Therapeutics is a Danish biotechnology company that develops tumor-specific antibodies using its proprietary SMART-Phage™ antibody discovery platform targeting cancer-associated Tn/STn glycoepitopes. The company generates therapeutic antibody candidates for modalities such as ADCs, bispecifics, CAR-T and radiolabeled therapies and pursues partnership deals with upfront, milestone and royalty components.
Explore Combotope Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.